Skip to main content

Table 1 Previously published cases of IMT of the breast

From: Anaplastic lymphoma kinase-positive inflammatory myofibroblastic tumor of the breast: a case report and review of the literature

Case

Author

Year

Age

Sex

Location

Size (cm)

ALK

Past trauma or surgery

Follow-up

Outcome

1

Pettinato et al. [6]

1988

29

F

Right

4.5

–

–

NED 30 months

–

2

Coffin et al. [7]

1995

13

F

Right

4

–

–

NED 12 months

–

3

Chetty et al. [8]

1997

16

F

Right

2

–

–

NED 12 months

–

4

Chetty et al. [8]

1997

46

F

Right

2

–

–

NED 12 months

–

5

Chetty et al. [8]

1997

18

F

Right

8

–

–

NED 6 months

–

6

Yip et al. [9]

1997

66

F

Left

3

–

None

Recurrence 12 months

Survival

7

Gobbi et al. [10]

1999

86

F

Left

1.5

–

–

–

–

8

Sastre-Garau et al. [11]

2002

64

F

Right

3

Neg

None

NED 33 months

–

9

Haj et al. [12]

2003

31

F

Right

1.8

–

None

–

–

10

Zardawi et al. [13]

2003

79

F

Right

1.5

Neg

–

Recurrences 108 months

Survival

11

Ilvan et al. [14]

2005

60

F

Right

1

Neg

None

NED 85 months

Survival

12

Khanafsar et al. [15]

2005

33

F

Left

2

Neg

None

Recurrence 3 months

Survival

13

Khanafsar et al. [15]

2005

75

F

Left

3

Neg

None

NED 14 months

Survival

14

Khanafsar et al. [15]

2005

47

F

Right

2

Neg

Surgery (right)

NED 12 months

Survival

15

Zen et al. [16]

2005

46

F

Left

1.6

–

–

NED 12 months

Survival

16

Akbulut et al. [17]

2007

38

F

Left

1

Neg

None

NED 12 months

Survival

17

Kim et al. [18]

2009

60

F

Left

1.5

Neg

None

NED 24 months

Survival

18

Park et al. [19]

2009

47

F

Right

3.5

–

None

NED 36 months

Survival

19

Hill et al. [20]

2010

53

F

Right

3.5

Neg

None

–

–

20

Sari et al. [21]

2011

54

F

Left

2.7

–

None

NED 4 months

Survival

21

Vecchio et al. [22]

2011

22

M

Left

7

Neg

Trauma (left)

NED 10 months

Survival

22

Zhou et al. [23]

2013

46

F

Right

1.1

Pos

None

NED 60 months

Survival

23

Li et al. [24]

2013

39

F

Left

4.5

Pos

None

NED 24 months

Survival

24

Zhao et al. [25]

2013

56

F

Right

4

Pos

None

Recurrence and metastasis 3,7,10 months

–

25

Bosse et al. [26]

2014

23

F

Left

2

Pos

None

NED 12 months

Survival

26

Xing et al. [27]

2014

56

F

Right

9

–

None

Recurrence and metastasis 2 months

Death

27

Kovacs et al. [28]

2015

31

F

Left nipple

1.6

Pos

None

NED 60 months

Survival

28

Markopoulos et al. [29]

2015

67

F

Left

1

Neg

None

NED 6 months

Survival

29

Choi et al. [30]

2015

27

F

Right

3

Neg

None

Recurrence and metastasis 24 months

–

30

Talu et al. [31]

2016

38

F

Left

1.5

Neg

None

NED 16 months

Survival

31

Siraj et al. [32]

2017

60

M

Left

15

Neg

None

NED 6 months

Survival

32

Inoue et al. [33]

2018

16

F

Right

2.2

Pos

None

Metastasis 0 months

–

33

Fernandes-Acenero et al. [34]

2018

52

F

Right

5

–

–

NED 8 months

Survival

34

Mao et al. [35]

2018

43

F

Left

1.4

Neg

Surgery (left)

NED 12 months

Survival

35

Wei et al. [36]

2021

50

F

Right

4.5

Neg

Surgery (right)

NED 44 months

Survival

36

Present case

2022

52

F

Left

1.2

Pos

None

NED 18 months

Survival

  1. ー not mentioned or not source, F female, M male, Pos positive, Neg negative, NED no evidence of disease